Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]
*Sign up for news summaries and alerts from 340B Report